Reconstitution of TML uptake by SLC25A45 Bacterial expression of mitochondrial carriers and uptake assays was performed as described previously with modifications ( 2224 )
Retatrutide is a triple receptor agonist targeting GLP-1, GIP, and glucagon receptors, distinguishing it from approved agents such as semaglutide and tirzepatide
Mild pain during or immediately after injection, slight redness, and small bruises are common and usually resolve within a few days
If you handle the original dose well, your provider will likely recommend a gradual increase like the following: Weeks 5-8: 0.5 mg weekly Weeks 9-12: 1 mg weekly Weeks 13-16: 1.7 mg weekly This careful increase continues until you reach the maintenance dose, which could be up to 2.4 mg weekly for many patients
Dudum said the companies view the Wegovy deal as a first step and plan to partner on additional offerings, though he didnt give specifics